1. Home
  2. LEGN vs AGI Comparison

LEGN vs AGI Comparison

Compare LEGN & AGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • AGI
  • Stock Information
  • Founded
  • LEGN 2014
  • AGI 2003
  • Country
  • LEGN United States
  • AGI Canada
  • Employees
  • LEGN N/A
  • AGI N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • AGI Precious Metals
  • Sector
  • LEGN Health Care
  • AGI Basic Materials
  • Exchange
  • LEGN Nasdaq
  • AGI Nasdaq
  • Market Cap
  • LEGN 9.1B
  • AGI 7.6B
  • IPO Year
  • LEGN 2020
  • AGI 1999
  • Fundamental
  • Price
  • LEGN $38.19
  • AGI $17.54
  • Analyst Decision
  • LEGN Strong Buy
  • AGI Strong Buy
  • Analyst Count
  • LEGN 13
  • AGI 5
  • Target Price
  • LEGN $81.46
  • AGI $22.25
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • AGI 2.7M
  • Earning Date
  • LEGN 11-12-2024
  • AGI 11-06-2024
  • Dividend Yield
  • LEGN N/A
  • AGI 0.57%
  • EPS Growth
  • LEGN N/A
  • AGI 18.31
  • EPS
  • LEGN N/A
  • AGI 0.60
  • Revenue
  • LEGN $520,183,000.00
  • AGI $1,225,700,000.00
  • Revenue This Year
  • LEGN $110.04
  • AGI $30.66
  • Revenue Next Year
  • LEGN $77.16
  • AGI $13.99
  • P/E Ratio
  • LEGN N/A
  • AGI $30.24
  • Revenue Growth
  • LEGN 122.96
  • AGI 22.50
  • 52 Week Low
  • LEGN $38.02
  • AGI $11.24
  • 52 Week High
  • LEGN $70.13
  • AGI $21.45
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.40
  • AGI 26.76
  • Support Level
  • LEGN $38.94
  • AGI $17.67
  • Resistance Level
  • LEGN $41.87
  • AGI $18.26
  • Average True Range (ATR)
  • LEGN 2.20
  • AGI 0.64
  • MACD
  • LEGN -0.30
  • AGI -0.33
  • Stochastic Oscillator
  • LEGN 1.74
  • AGI 2.99

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About AGI Alamos Gold Inc.

Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has three operating mines in North America: Young-Davidson and Island Gold mines operate in Canada and the Mulatos and in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.

Share on Social Networks: